Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
EBOS Group Limited ( (AU:EBO) ) has issued an update.
EBOS Group Limited has announced the issuance of 5,153 ordinary fully paid securities on the ASX, effective June 13, 2025. This move, part of an employee incentive scheme, reflects the company’s efforts to enhance employee engagement and align their interests with shareholders, potentially impacting its market positioning positively.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services. The company focuses on distributing healthcare, medical, and pharmaceutical products across various markets.
Average Trading Volume: 79,497
Technical Sentiment Signal: Buy
Current Market Cap: A$6.97B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.